×
About 1,783 results

ALLMedicine™ Ovarian Insufficiency Center

Research & Reviews  662 results

Premature ovarian insufficiency - the need for a genomic map.
https://doi.org/10.1080/13697137.2021.1945025
Climacteric : the Journal of the International Menopause ... Cloke B, Rymer J

Jul 27th, 2021 - Premature ovarian insufficiency (POI) is a life-long disorder of heterogeneous etiology, presenting as adolescent primary amenorrhea in its most severe form, with an overall incidence of 1%. Idiopathic POI accounts for up to 70% of women with POI;...

Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
https://doi.org/10.1016/j.beem.2021.101561
Best Practice & Research. Clinical Endocrinology & Metabo... Armeni E, Paschou SA et. al.

Jul 19th, 2021 - The transition to menopause is associated with a changing hormonal milieu, leading to bothersome menopausal symptoms in the short-term and chronic health problems in the long-term. Premature ovarian insufficiency (POI) is characterized by the cess...

Autotransplantation of the ovarian cortex after in-vitro activation for infertility tre...
https://doi.org/10.1093/humrep/deab143
Human Reproduction (Oxford, England); Zhai J, Zhang J et. al.

Jul 17th, 2021 - Is it possible to establish a new in-vitro activation (IVA) protocol for infertility treatment? A new IVA procedure is an efficient and easily performed approach for infertility treatment of patients with diminished ovarian reserve (DOR). IVA of p...

Association of Variants in Vascular Endothelial Growth Factor A Gene and VEGFA Serum Le...
https://doi.org/10.1159/000517071
Gynecologic and Obstetric Investigation; Li Y, Liu F et. al.

Jul 12th, 2021 - The study aimed at investigating the association between the vascular endothelial growth factor A (VEGFA) genetic variants, the VEGFA serum level, and the primary ovarian insufficiency (POI) risk in Chinese Han women. An age-matched case-control s...

see more →

Guidelines  4 results

Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
https://allmedx.com/USPSTFPDF/hormone-therapy-clinical-summary.pdf

Dec 5th, 2017 - Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Population Postmenopausal women Postmenopausal women who have had a hysterectomy Recommendation Do not use combined estroge...

Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002044
Obstetrics and Gynecology;

Apr 21st, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

ESHRE Guideline: management of women with premature ovarian insufficiency.
https://doi.org/10.1093/humrep/dew027
Human Reproduction (Oxford, England); , Webber L et. al.

Mar 25th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific...
https://doi.org/10.1038/gim.2013.61
Genetics in Medicine : Official Journal of the American C... Monaghan KG, Lyon E et. al.

Jun 15th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...

see more →

Clinicaltrials.gov  15 results

Pilot E2 for Hypogonadal Women With CFBD
https://clinicaltrials.gov/ct2/show/NCT03724955

Apr 18th, 2019 - Cystic fibrosis (CF) is the most common fatal heritable disease in non-Hispanic whites; CF results in frequent lung infections, chronic inflammation and progressive lung failure. With advancements in medical care, patients with CF are living longe...

Ovarian Stem Cells From Women With Ovarian Insufficiency
https://clinicaltrials.gov/ct2/show/NCT01702935

Nov 2nd, 2018 - Early loss of human ovarian function results in a clinical condition known as primary ovarian insufficiency (POI) or premature ovarian failure (POF). This devastating condition renders women unable to have their own genetic child in more than 95% ...

Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT01197456

Oct 15th, 2018 - More than two million American women are breast cancer survivors. Approximately one-third of these women are premenopausal at diagnosis and face issues related to reproduction as they undergo cancer treatment. Ovarian function after breast cancer ...

In Vitro Follicle Activation
https://clinicaltrials.gov/ct2/show/NCT02496598

Aug 29th, 2018 - The purpose of this study is to evaluate the effectiveness of an experimental treatment, known as in vitro activation (IVA) of dormant ovarian follicles, for infertility in women diagnosed with primary ovarian insufficiency (POI; also known as pre...

Injections of Autologous PRP in Women With Primary Ovarian Insufficiency
https://clinicaltrials.gov/ct2/show/NCT03542708

Jun 13th, 2018 - Premature ovarian failure is a loss of normal function before age 40, leading to infertility and hypoestrogenism. While POI is sometimes called premature menopause, it is not the same thing as menopause. Women with POI may still have occasional ir...

see more →

News  26 results

Primary Ovarian Insufficiency Requires Long-term Management of Sequelae
https://www.medscape.com/viewarticle/951400

May 18th, 2021 - Primary ovarian insufficiency is not your mother's early menopause, Laurie McKenzie, MD, told attendees at the 2021 annual meeting of the American College of Obstetricians and Gynecologists. Known previously as primary ovarian failure, the syndrom...

Primary Ovarian Insufficiency Linked to Osteoporosis
https://www.medscape.com/viewarticle/947390

Mar 15th, 2021 - NEW YORK (Reuters Health) - Primary ovarian insufficiency (POI) was tied to an increased risk of osteoporosis in a large Canadian cohort study. "There is accumulating evidence demonstrating that an earlier menopause, which represents an early loss...

No Emerging Safety Concerns With 9-Valent HPV Vaccine
https://www.medscape.com/viewarticle/921541

Nov 21st, 2019 - NEW YORK (Reuters Health) - After three years of adverse-event surveillance and more than 28 million doses, the nine-valent human papillomavirus (9vHPV) vaccine shows no new or unexpected safety concerns, according to results from two studies. "Th...

UK Guidelines Quiz – Menopause: Diagnosis and Management
https://www.medscape.com/viewarticle/919637

Oct 18th, 2019 - In the reviewed guideline: ‘Menopause: diagnosis and management’ the National Institute for Health and Care Excellence (NICE) aims to improve the consistency of support and information provided to women in menopause. It includes guidance for the d...

No increase in primary ovarian insufficiency with HPV vaccine
https://www.mdedge.com/obgyn/article/172987/vaccines/no-increase-primary-ovarian-insufficiency-hpv-vaccine
Bianca Nogrady

Aug 21st, 2018 - The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency, according to researchers. Choreograph/Thinkstock Allison L.

see more →

Patient Education  6 results see all →